Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can your mindset help heal a leg ulcer? new study investigates

NCT ID NCT01673412

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study followed 104 people with venous leg ulcers to see which factors were linked to complete healing after 24 weeks. Researchers looked at medical history, wound size, and also psychological and social factors like mood and self-esteem. The goal was to find better ways to predict healing and improve care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help doctors better predict which leg ulcers will heal, allowing for more personalized treatment plans.
What could go wrong
This is an observational study, not a treatment trial. It only identifies possible factors linked to healing, not causes. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

104 people

The number who actually took part.

Start date

Jan 2003

Finished

Dec 2008

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ambulatory or hospitalized patients * patients over 50 years old * one or more venous leg ulcer, lasting for 1 month or more * wound area more than 1 cm2 * clinical findings consistent with established venous disease (skin hyperpigmentation, varicose veins, lipodermatosclerosis), confirmed by venous Doppler duplex ultrasonography performed during the preceding 6 months * absence of significant arterial insufficiency assessed by clinical findings (intermittent claudication or resting pain, necrotic or distal foot wound) and by an ankle brachial index (ABI) ≥0.8 * ability to give informed consent * ability to be followed for 24 weeks Exclusion Criteria: * ongoing systemic diseases known to be associated with pyoderma gangrenosum or necrotizing vasculitis * corticosteroid, cytotoxic or immunosuppressant drug use during the preceding 3 months * hypertensive leg ulcer * foot ulcer * ABI \< 0.8

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Leg ulcer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU Dupuytren - Dermatologie

    Limoges, 87042, France

  • CHU Bichat - Service de Dermatologie

    Paris, 75018, France

  • CHU Bocage - Dermatologie

    Dijon, 21034, France

  • CHU Clémenceau - Dermatologie

    Caen, 14033, France

  • CHU Michallon - Dermatologie

    Grenoble, 38043, France

  • CHU Pontchaillou

    Rennes, 35033, France

  • CHU Robert Debré

    Reims, 51092, France

  • CHU Trousseau - Dermatologie

    Tours, 37044, France

  • CHU de Brest - Dermatologie

    Brest, 29609, France

  • Cabinet de Dermatologie 1,rue dembarrère

    Tarbes, 65000, France

  • Cabinet de Dermatologie 43, rue Jean Lecanuet

    Rouen, 76000, France

  • Centre Hospitalier - Service de Médecine Interne

    Lens, 62307, France

  • Centre Hospitalier Intercommunal Poissy Saint Germain

    Saint-Germain-en-Laye, 78100, France

  • Centre Hospitalier Laennec - Dermatologie

    Quimper, 29107, France

  • Centre Hospitalier de Valence - Dermatologie

    Valence, 26000, France

  • Centre Hospitalo-Universitaire d'Amiens - Dermatologie

    Amiens, 80000, France

  • Hôpital Beauregard

    Thionville, 57100, France

  • Hôpital Broussais - Rééducation Vasculaire

    Paris, 75674, France

  • Hôpital C. Foix - Service de Gérontologie

    Ivry, 94205, France

  • Hôpital Charles NICOLLE - Service de Dermatologie

    Rouen, 76031, France

  • Hôpital Claude Huriez - Clinique Dermatologique

    Lille, 59037, France

  • Hôpital Fournier

    Nancy, 54000, France

  • Hôpital Robert Boulin - Dermatologie

    Libourne, 33500, France

  • Hôpital Rothschild - Consultation de Dermatologie

    Paris, 75012, France

  • Hôpital SAint Charles - Dermatologie

    Montpellier, 34295, France

  • Hôpital Saint Jacques - Dermatologie 1

    Besançon, 25030, France

  • Hôpital Saint Louis - Service de Dermatologie

    Paris, 75475, France

  • Hôpital Saint Philibert - Dermatologie

    Lomme, 59462, France

  • Hôpital Saint Vincent de Paul - Médecine interne et Gériatrie I

    Amiens, 80000, France

  • Hôpital Sainte Marguerite - Dermatologie

    Marseille, 13009, France

  • Hôpital Victor Dupouy - Dermatologie

    Argenteuil, 95100, France

  • Hôpital d'Instruction des Armées Desgenettes

    Lyon, 69998, France

  • Hôpital du Haut Levêque - Dermatologie

    Pessac, 33604, France

  • Hôpitaux Civils de Colmar - Service de Dermatologie

    Colmar, 68024, France

  • Le Royal Parc - Dermatologie

    Saint-Brieuc, 22000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.